This is a StreetInsider.com Premium Only Page

Omeros (OMER) – StreetInsider.com Reports

Nov 10, 2023 01:52 PM Cantor Fitzgerald Downgrades Omeros Corp. (OMER) to Neutral

Nov 9, 2023 04:29 PM Omeros (OMER) Misses Q3 EPS by 21c

Oct 19, 2023 08:31 AM Omeros (OMER) Appoints Andreas Grauer as Chief Medical Officer

Oct 16, 2023 07:32 AM Omeros (OMER) says narsoplimab did not achieve statistically significant improvement over placebo in Phase 3 trial

Oct 16, 2023 07:25 AM Omeros (OMER) Halted, News Pending

Aug 9, 2023 08:08 AM Omeros (OMER) Misses Q2 EPS by 13c

Jun 1, 2023 11:01 AM Omeros (OMER) Announces Late-Breaking Presentation of OMS906 Data

May 9, 2023 04:31 PM Omeros (OMER) Misses Q1 EPS by 4c

Apr 25, 2023 09:25 AM Omeros (OMER) Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria

Apr 10, 2023 08:45 AM Omeros (OMER) Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program

Mar 10, 2023 03:37 PM Omeros (OMER) Confirms Absence of Financial Exposure to Silicon Valley Bank

Feb 6, 2023 08:54 AM Omeros (OMER) Climbs 60% After Announcing Announcing $200m Milestone Payment from Rayner Surgical

Feb 6, 2023 08:51 AM Omeros (OMER) announces $200m milestone payment from Rayner Surgical

Dec 23, 2022 10:02 AM Increasing unusual call volume: OMER SONO EH AZUL APRN CTSH AQN

Dec 8, 2022 07:21 AM UBS Downgrades Omeros Corp. (OMER) to Neutral

Nov 10, 2022 06:34 AM Omeros Corp. (OMER) PT Lowered to $13 at Cantor Fitzgerald

Nov 9, 2022 04:59 PM Omeros (OMER) Files $300M Mixed Shelf

Nov 8, 2022 11:33 AM BofA Securities Downgrades Omeros Corp. (OMER) to Underperform

Nov 8, 2022 08:36 AM Omeros (OMER) Receives Decision from FDA on Formal Dispute Resolution Request for Narsoplimab

Oct 3, 2022 07:11 AM Omeros (OMER) Enters Royalty Monetization Transaction with DRI Healthcare Trust

Sep 15, 2022 09:06 AM Omeros (OMER) Reports Narsoplimab Reduced Mortality Risk in Critically Ill COVID-19 Patients in I-SPY COVID Trial

Aug 17, 2022 08:40 AM Omeros (OMER) Receives Interim Response from FDA on Formal Dispute Resolution Request for Narsoplimab

Jul 29, 2022 08:45 AM Omeros (OMER) Granted FDA Orphan Drug Designation to OMS906

Jun 17, 2022 07:01 AM Companies with NDRs 6/17

Jun 8, 2022 08:41 AM BofA Securities Downgrades Omeros Corp. (OMER) to Neutral

May 18, 2022 07:43 AM Omeros Corp's (OMER) Narsoplimab Approval Pathway is More Challenging, PT Lowered to $12 at BofA Securities

Apr 27, 2022 05:55 AM Veru (VERU) and Opiant (OPNT) Top Cantor Fitzgerald's List of Largest Short Interest Increases

Apr 20, 2022 08:45 AM Omeros (OMER) Announces Publication Detailing Pivotal Trial Results for Narsoplimab in HSCT-TMA

Apr 12, 2022 05:53 AM Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Clarus (CRXT) and United Therapeutics (UTHR) Seeing Biggest Short Interest Increases

Mar 28, 2022 11:10 AM UPDATE: HUTCHMED (China) (HCM) and Viatris (VTRS) Top Cantor Fitzgerald's List of Biggest Short Interest Increases, Heron (HRTX) and Omeros (OMER) Continue to Have Higher Short Floats

Mar 10, 2022 05:45 AM Heron Therapeutics (HRTX) and Omeros (OMER) Top Cantor Fitzgerald's Most Shorted List; Amgen (AMGN) and PDS (PDSB) Seeing Biggest Increases

Mar 2, 2022 06:24 AM Needham & Company Maintains Hold Rating on Omeros (OMER), Reiterates Belief FDA Will Require Additional Trial for narsoplimab

Mar 2, 2022 06:19 AM Omeros Corp. (OMER) PT Lowered to $15 at BofA Securities

Mar 1, 2022 04:37 PM Omeros (OMER) Misses Q4 EPS by 40c

Jan 20, 2022 05:36 AM Omeros (OMER) Submits Response to FDA Regarding the BLA for Narsoplimab in the Treatment of HSCT-TMA

Jan 18, 2022 06:35 AM Omeros Corp. (OMER) PT Lowered to $20 at Cantor Fitzgerald

Dec 28, 2021 05:55 AM VYNE Therapeutics (VYNE) and Ardelyx (ARDX) Top Cantor Fitzgerald's Most Shorted Biotech List

Dec 2, 2021 09:28 AM Pre-Open Stock Movers 12/02: (CFVI) (OMER) (DWAC) Higher; (TANH) (KIRK) (LE) Lower (more...)

Dec 2, 2021 07:31 AM Omeros (OMER) to Sell OMIDRIA Franchise to Rayner Surgical in Transaction Valued in Excess of $1 Billion

Nov 11, 2021 08:07 AM Omeros Corp. (OMER) PT Lowered to $12 at UBS

Nov 9, 2021 05:03 PM Omeros (OMER) Tops Q3 EPS by 16c

Nov 5, 2021 08:41 AM Omeros (OMER) Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial

Oct 21, 2021 04:11 AM Increasing unusual put option volume: INDA SIRI EAT ATUS OMER

Oct 18, 2021 12:59 PM CRL is a Negative, but Omeros (OMER) Stock is Trading Far Below Fundamental Value - Analyst

Oct 18, 2021 12:48 PM Omeros Corp. (OMER) CRL Not a Surprise, Stock Cheap - Cantor Fitzgerald

Oct 18, 2021 09:23 AM Pre-Open Stock Movers 10/18: (ADMP) (OYST) (INFI) Higher; (RVNC) (OMER) (MNKD) Lower (more...)

Oct 18, 2021 06:32 AM Omeros (OMER) Receives CRL From FDA for Narsoplimab in the Treatment of HSCT-TMA

Oct 15, 2021 09:07 AM Omeros Corp. (OMER) PT Lowered to $13 at UBS

Oct 8, 2021 04:41 AM JPMorgan Downgrades Omeros Corp. (OMER) to Underweight

Oct 6, 2021 06:48 AM Omeros Corp. (OMER) PT Lowered to $19 at H.C. Wainwright